Teva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing Authorization in Several European Countries
OncoGenex Announces Cedar™ Clinical Trial Evaluating Apatorsen in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer is Now Open for Enrollment
Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market
BioLight Announces Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
QRxPharma Announces Board Resignations
Widening investment-grade credit spreads and rising interest rates lead to losses.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Corporate credit spreads are fairly valued--albeit at the tight end of the range that we view as fairly valued.